UAlg researcher receives 1 million to develop project for children with rare diseases
July 4, 2023 - 11:47
This funding follows another one for the project “CureCSB – Development of a Gene Therapy for Cockayne Syndrome Type B”
TAG: CBMR
Research involving CBMR from the University of Algarve wins award
November 23, 2020 - 18:01
One of the main authors of the study was Clévio Nóbrega, from the Center for Research in Biomedicine (CBMR)
UAlg researchers Tomás Azevedo and Adriana Marcelo awarded at an international congress
February 6, 2020 - 10:12
Awards were won during the international congress Meeting of the Portuguese Society of Genetics (IMPSG-2020)
UAlg researchers are part of the Melo e Castro Award winning team
November 27, 2019 - 16:01
Project «relies on the important contribution of the Center for Research in Biomedicine»
UAlg researchers reach "important conclusions" about heart disease
September 3, 2019 - 15:30
Group is coordinated by José Bragança
Algarve researcher will try to develop new therapy for neurodegenerative diseases
March 20, 2019 - 10:39
Project starts in May
UAlg Researchers Discovery May Contribute to Bladder Cancer Treatment
January 14, 2019 - 10:21
Data revealed by Algarve researchers bring new perspectives on the biology of cancer
UAlg's research on flounder gives clues to the thyroid's influence on human growth
November 29, 2018 - 13:54
Research involved CCMar and CBMR research centers
CBMR from the University of the Algarve is the new partner of the Cancer Drug Development Forum
October 19, 2018 - 11:52
CBMR will broadcast events, workshops, training actions and other activities that will allow accelerating the development of anti-cancer drugs
UAlg Researcher Discovers How to Delay Effects of Incurable Disease
September 24, 2018 - 10:55
The research carried out by the team coordinated by Clévio Nóbrega was based on the drug cordycepin, already used for other purposes.
University of Algarve researchers fight for lower drug prices
August 2, 2018 - 9:21
Researcher suggests taxpayers are paying twice for drugs
